SCHEMBL27265481

SCHEMBL27265481

C=C(C)C(=O)OC(=O)C(C)=CCCCCCCCC

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.50
EP300 Q09472 1/20 0.44
FAAH O00519 4/20 0.37
KMT2A Q03164 2/20 0.37
MEN1 O00255 1/20 0.37
CYP3A4 P08684 1/20 0.37
TERT O14746 3/20 0.36
MAPT P10636 2/20 0.36
BLM P54132 2/20 0.36
HSD17B10 Q99714 2/20 0.36
FABP4 P15090 2/20 0.36
GMNN O75496 1/20 0.36
USP2 O75604 1/20 0.36
LMNA P02545 1/20 0.36
CYP1A2 P05177 1/20 0.36
POLB P06746 1/20 0.36
CYP2C9 P11712 1/20 0.36
ALOX15 P16050 1/20 0.36
APEX1 P27695 1/20 0.36
CYP2C19 P33261 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27655746 1.00 TSHR (0.50) TSHREP300FAAHKMT2AMEN1
SCHEMBL27516600 1.00 TSHR (0.50) TSHREP300FAAHKMT2AMEN1
SCHEMBL27993898 1.00 TSHR (0.50) TSHREP300FAAHKMT2AMEN1
SCHEMBL27265352 0.98 TSHR (0.47) TSHREP300FAAHKMT2AMEN1
SCHEMBL6425465 0.93 TSHR (0.44) TSHREP300CYP2C19F7F3
SCHEMBL14890135 0.91 EP300 (0.52) TSHREP300FAAHKMT2AMEN1
SCHEMBL9242927 0.91 EP300 (0.52) TSHREP300FAAHKMT2AMEN1
SCHEMBL3433546 0.91 EP300 (0.52) TSHREP300FAAHKMT2AMEN1
SCHEMBL3437706 0.91 EP300 (0.52) TSHREP300FAAHKMT2AMEN1
SCHEMBL9656545 0.91 EP300 (0.52) TSHREP300FAAHKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102753156-B Oral complex formulation comprising probiotic composition and 5-HT4 receptor agonist and method for preparing same HANMI HOLDINGS Co.,Ltd. (KR) 2014-10-08 CN claimed
CN-102753156-A Oral complex formulation comprising probiotic composition and 5-HT4 receptor agonist and method for preparing same HANMI HOLDINGS CO LTD 2012-10-24 CN claimed
CN-102753156-B Oral complex formulation comprising probiotic composition and 5-HT4 receptor agonist and method for preparing same HANMI HOLDINGS Co.,Ltd. (KR) 2014-10-08 CN disclosed
CN-102753156-A Oral complex formulation comprising probiotic composition and 5-HT4 receptor agonist and method for preparing same HANMI HOLDINGS CO LTD 2012-10-24 CN disclosed
CN-1017046-B Fluorine-containing mono-or polyalkylene glycol derivative and process for producing the same MITSUI PETROCHEMICAL IND (JP) 1992-06-17 CN disclosed
CN-1032160-A Fluorine-containing list or polyalkylene glycol and preparation method thereof MITSUI PETROCHEMICAL IND (JP) 1989-04-05 CN disclosed